These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
961 related items for PubMed ID: 18363007
1. Predictors of variceal bleed among patients with liver cirrhosis in the era of sclerotherapy. Varghese J, Cherian JV, Solomon R, Jayanthi V. Singapore Med J; 2008 Mar; 49(3):239-42. PubMed ID: 18363007 [Abstract] [Full Text] [Related]
3. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices. Nevens F, Broeckaert L, Rutgeerts P, Van Steenbergen W, Fevery J. Hepatogastroenterology; 1995 Aug; 42(6):979-84. PubMed ID: 8847055 [Abstract] [Full Text] [Related]
4. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Abid S, Jafri W, Hamid S, Salih M, Azam Z, Mumtaz K, Shah HA, Abbas Z. Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890 [Abstract] [Full Text] [Related]
5. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C, Papaxoinis C, Manolakopoulos S, Panani A, Raptis SA. Hepatology; 2004 Jun; 39(6):1623-30. PubMed ID: 15185303 [Abstract] [Full Text] [Related]
6. Prophylactic endoscopic sclerotherapy in patients with liver cirrhosis, portal hypertension, and esophageal varices. Paquet KJ, Kuhn R. Hepatogastroenterology; 1997 Jun; 44(15):625-36. PubMed ID: 9222663 [Abstract] [Full Text] [Related]
14. Emergency sclerotherapy for control of acute oesophageal variceal bleeding using 3% aqueous phenol: a 15-year experience. Desai CS, Shah SR, Mathur SK. ANZ J Surg; 2004 Jun; 74(6):460-2. PubMed ID: 15191482 [Abstract] [Full Text] [Related]
15. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Roccarina D, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Benmassaoud A, Plaz Torres MC, Iogna Prat L, Csenar M, Arunan S, Begum T, Milne EJ, Tapp M, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS. Cochrane Database Syst Rev; 2021 Apr 06; 4(4):CD013121. PubMed ID: 33822357 [Abstract] [Full Text] [Related]
17. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Am J Gastroenterol; 1999 Nov 06; 94(11):3292-6. PubMed ID: 10566732 [Abstract] [Full Text] [Related]
18. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F, Baez AL, Pandula R, Walser E, Lau DT. J Gastroenterol Hepatol; 2005 Mar 06; 20(3):474-81. PubMed ID: 15740494 [Abstract] [Full Text] [Related]
19. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding. Tiani C, Abraldes JG, Bosch J. Dig Liver Dis; 2008 May 06; 40(5):318-27. PubMed ID: 18291732 [Abstract] [Full Text] [Related]